Tech Company Financing Transactions
Calimmune Funding Round
Alexandria Venture Investments, RA Capital and private investors joined a $15 million Series B funding round for Calimmune. The financing round closed on 5/28/2015.
Transaction Overview
Company Name
Announced On
5/28/2015
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Proceeds Purpose
Proceeds will be used to progress the company's ongoing HIV/AIDS clinical trials, advanced technology research programs and general corporate operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5151 East Broadway Blvd. 1020
Tucson, AZ 85711
USA
Tucson, AZ 85711
USA
Phone
Website
Email Address
Not Recorded
Overview
We design transformational gene therapies that aim to enhance the body s own defenses to defeat disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Louis Breton
Chief Financial Officer
Bhavin Raval
Chief Medical Officer
Salim Yazji
Chief Scientific Officer
Jeffrey Bartlett
VP - Bus. Development
Margo Lunsford
VP - Human Resources
Tana Session
VP - Regulatory Affairs
Geoff Symonds
Browse more venture capital transactions:
Prev: 5/28/2015: Freedom Meditech venture capital transaction
Next: 5/29/2015: Snap venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs